Diabetes mellitus is a complex metabolic disorder characterized by chronic hyperglycemia, and associated with long-term damage and dysfunction of various organs. Management of diabetes is therefore vital and involves maintaining euglycemia as much as possible by reducing blood glucose and by increasing insulin sensitivity and peripheral glucose uptake.
Hyperglycemia in diabetes promotes auto-oxidation of glucose to form free radicals. The generation of free radicals beyond the scavenging abilities of endogenous antioxidant defenses results in macro- and microvascular dysfunction.
Supplementation of the mainstream therapy with an agent having anti-diabetic and anti-oxidant properties to minimize the diabetes complications in the long run and to squeeze the unwanted effects of the rationale anti-diabetics to achieve glucose hemostasis is the goal of GLUCOVEG.